Research Article
[Retracted] MiR-139-5p Inhibits the Development of Gastric Cancer through Targeting TPD52
Table 2
Relationship between miR-139-5p expression and clinicopathological characteristics of GC patients.
| Characteristics | Cases | MiR-139-5p | P value | High | Low |
| Age (years) | | | | 0.586 | ≥60 | 30 | 11 | 19 | | <60 | 37 | 17 | 20 | | Gender | | | | 0.421 | Male | 40 | 18 | 22 | | Female | 27 | 10 | 17 | | Tumor size (cm) | | | | 0.052 | <5 | 42 | 18 | 24 | | ≥5 | 25 | 10 | 15 | | TNM stage | | | | | I + II | 47 | 20 | 27 | | III + IV | 20 | 8 | 12 | | Differentiation | | | | 0.199 | Low | 35 | 15 | 20 | | Moderate or well | 32 | 13 | 19 | | Lymph metastasis | | | | | Present | 50 | 20 | 30 | | Absent | 17 | 8 | 9 | |
|
|
Statistical analyses were performed by the χ2 test. was considered significant. |